Showing 66,121 - 66,140 results of 100,888 for search '(( 5 ((we decrease) OR (step decrease)) ) OR ( 5 ((a decrease) OR (nn decrease)) ))', query time: 1.95s Refine Results
  1. 66121

    Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  2. 66122

    Data Sheet 11_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  3. 66123

    Data Sheet 2_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  4. 66124

    Data Sheet 10_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  5. 66125

    Data Sheet 12_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  6. 66126

    Data Sheet 6_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
  7. 66127

    Hematoxylin and eosin staining with histomorphometric analysis of outflow vein removed from Iex-1<sup>−/−</sup> and WT animals at day 28 after fistula placement. by Akshaar Brahmbhatt (551498)

    Published 2014
    “…Pooled data from the mean neointima area from <i>Iex-1</i> KO and WT animals are shown in <b>c.</b> There is a significant decrease in the mean area of the neointima in the <i>Iex-1</i> KO animals when compared to WT controls (P<0.05). …”
  8. 66128

    Table_1_Palmelloid formation in the Antarctic psychrophile, Chlamydomonas priscuii, is photoprotective.DOCX by Beth Szyszka-Mroz (13539646)

    Published 2022
    “…Compared to single cells, palmelloids of C. priscuii showed a decrease in the abundance of light-harvesting complex II (LHCII) proteins with a 2-fold higher Chl a/b ratio. …”
  9. 66129

    Table_2_Palmelloid formation in the Antarctic psychrophile, Chlamydomonas priscuii, is photoprotective.DOCX by Beth Szyszka-Mroz (13539646)

    Published 2022
    “…Compared to single cells, palmelloids of C. priscuii showed a decrease in the abundance of light-harvesting complex II (LHCII) proteins with a 2-fold higher Chl a/b ratio. …”
  10. 66130

    Table_2_Evaluation of the Prevalence and Risk Factors for Undernutrition in Hospitalized Dogs.XLSX by Jenifer Molina (5696585)

    Published 2018
    “…Anorexia at admission (P < 0.001; OR 5.67, 95% CI: 2.23 to 15.47) was associated with a higher risk of death. …”
  11. 66131

    Table_1_Evaluation of the Prevalence and Risk Factors for Undernutrition in Hospitalized Dogs.DOCX by Jenifer Molina (5696585)

    Published 2018
    “…Anorexia at admission (P < 0.001; OR 5.67, 95% CI: 2.23 to 15.47) was associated with a higher risk of death. …”
  12. 66132

    Image_1_Palmelloid formation in the Antarctic psychrophile, Chlamydomonas priscuii, is photoprotective.TIF by Beth Szyszka-Mroz (13539646)

    Published 2022
    “…Compared to single cells, palmelloids of C. priscuii showed a decrease in the abundance of light-harvesting complex II (LHCII) proteins with a 2-fold higher Chl a/b ratio. …”
  13. 66133

    Image_2_Palmelloid formation in the Antarctic psychrophile, Chlamydomonas priscuii, is photoprotective.TIFF by Beth Szyszka-Mroz (13539646)

    Published 2022
    “…Compared to single cells, palmelloids of C. priscuii showed a decrease in the abundance of light-harvesting complex II (LHCII) proteins with a 2-fold higher Chl a/b ratio. …”
  14. 66134

    Table_1_The inflammatory and metabolic status of patients with sudden-onset sensorineural hearing loss.DOCX by Jônatas Bussador do Amaral (13789027)

    Published 2024
    “…/mL). Adiponectin showed a decrease from 553.7 ng/mL in V1 to 454.4 ng/mL in V3.…”
  15. 66135

    Image_3_Palmelloid formation in the Antarctic psychrophile, Chlamydomonas priscuii, is photoprotective.TIF by Beth Szyszka-Mroz (13539646)

    Published 2022
    “…Compared to single cells, palmelloids of C. priscuii showed a decrease in the abundance of light-harvesting complex II (LHCII) proteins with a 2-fold higher Chl a/b ratio. …”
  16. 66136

    Image_4_Palmelloid formation in the Antarctic psychrophile, Chlamydomonas priscuii, is photoprotective.TIF by Beth Szyszka-Mroz (13539646)

    Published 2022
    “…Compared to single cells, palmelloids of C. priscuii showed a decrease in the abundance of light-harvesting complex II (LHCII) proteins with a 2-fold higher Chl a/b ratio. …”
  17. 66137

    DataSheet1_Fabrication and characterization of polycaprolactone/chitosan nanofibers containing antibacterial agents of curcumin and ZnO nanoparticles for use as wound dressing.pdf by Pezhman Mosallanezhad (13847908)

    Published 2022
    “…SEM images confirmed the nanofibrous structure of samples with 100 ± 5 to 212 ± 25 nm in average diameter. Elemental analysis of nanofibers showed a good distribution of ZnO along nanofibers which not only caused decreasing in nanofiber diameter but also increased tensile strength of nanofibers up to 2.9 ± 0.5 MPa and with good elongation at break of 39 ± 2.9. …”
  18. 66138

    Supplementary Material for: Differential Expression of Stem Cell Markers in Human Adamantinomatous Craniopharyngioma and Pituitary Adenoma by Chang C.V. (4161655)

    Published 2016
    “…The RT-qPCR array showed an increased expression of <i>MKI67,</i><i>OCT4</i>/<i>POU5F1,</i> and <i>DLL4 </i>in all tumours. <i>NANOG </i>was decreased in ACP. …”
  19. 66139
  20. 66140

    Histologic analysis of bone erosions in mice with collagen-induced arthritis (CIA) after treatment with IFN-β by Judith van Holten (26438)

    Published 2011
    “…Sections were scored on a 4-point scale. RANKL staining; a decrease of RANKL-positive cells was observed in the group of animals treated with 2.5 μg IFN-β, although not statistically significant (= 0.07). c-Fos staining; the number of c-Fos-positive cells was significantly reduced in the mice treated with daily 2.5 μg per injection IFN-β (= 0.04). …”